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Abstract
Primary care physicians occupy a
vital position to impact many
devastating conditions, especially
those dependent upon early diagnosis,
such as skin cancer. Skin cancer is the
most common cancer in the United
States and despite improvements in
skin cancer therapy, patients with a
delay in diagnosis and advanced
disease continue to have a grave
prognosis. Due to a variety of barriers,
advanced stages of skin cancer are
more prominent in rural populations.
In order to improve early diagnosis
four things are paramount: increased
patient participation in prevention
methods, establishment of screening
guidelines, increased diagnostic
accuracy of malignant lesions, and
easier access to dermatologists. Recent
expansion in smartphone mobile
application technology offers simple
ways for rural practitioners to address
these problems. More than 100,000
health related applications are
currently available, with over 200
covering dermatology. This review
will evaluate the newest and most
useful of those applications offered to
enhance the prevention and early
diagnosis of skin cancer, particularly
in the rural population.

Introduction
Skin cancer is the most common
cancer in the United States. More
than 3.5 million new cases occur
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annually, and these numbers
continue to rise.1 Of the three most
common types of skin cancer,
melanoma is the most deadly,
accounting for more than 75% of all
skin-cancer deaths.2 The lethality
of melanoma is directly dependent
upon the stage of the cancer at the
time of diagnosis.3 If diagnosed
early, almost all skin cancer can
be successfully treated. However,
those with delayed diagnosis
and advanced disease continue
to have a grave prognosis.4
Many barriers must be overcome
in order to increase early detection
and survival rates. Low patient
participation in prevention methods,
a lack of appropriate screening,
inaccurate diagnoses, and significant
time backlogs for examinations by
dermatologists are problems that
must be addressed.5-9 Primary care
physicians (PCPs) and physician
extenders are the first line of defense
to address these factors. The
demand for effective and efficient
delivery of health care by PCPs will
become even greater in the near
future, as a massive shortage of
physicians of more than 91,000 is
expected by 2020.10 All areas will
surely be affected; however, the
impact on preexisting underserved
rural populations will be more
severe. Fortunately, new innovations
in smartphone mobile technology
provide a means to assist PCPs
when dermatology referral is limited.
A smartphone is a mobile
telephone that functions as a touch
screen computer, digital camera,
and GPS navigation unit. It also acts
as a platform for running software
programs called mobile applications,
or “apps.” A great number of health
care providers and future physicians
are using mobile apps to deliver
more efficient and effective health
care.11-14 These apps function as
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decision support tools, clinical
references, patient-education tools,
and provide online consultation
to areas where specialists are
limited. Recent expansion in app
technology offers assistance to
rural physicians in the prevention,
screening, and management of
skin cancer. There are more than
5,860 medical apps currently
available, and this review will be
evaluating the newest and most
useful for dermatological diagnosis
in a rural setting (Table 1).15

Primary Prevention
Applications
Ultraviolet radiation (UVR)
exposure is a major risk factor for
the development of skin cancer.16-19
Despite being an established
carcinogen, many Americans
fail to follow sun protection
recommendations and a substantial
portion of adolescents and young
adults continue to engage in indoor
tanning.20-21 Even more disturbing
is the fact that only 60% of parents
apply sunscreen and only 25% use
shade to protect their children.22
People from underserved groups
are even less inclined to practice
protective behaviors.23 Accordingly,
the U.S. Preventive Service Task
force (USPSTF) now recommends
PCPs to counsel children and
young adults on ways to minimize
their exposure to UV radiation.24
The Environmental Protection
Agency developed a standard
by which the strength of UVR is
measured, called the UV index
(UVI). Multiple mobile applications
for UVI are available, functioning
as tools to enhance daily
awareness and increase proper
sun protection. After review of the
apps, the following was the most
inclusive and cost efficient.
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App: UV US – Weather Forecast,
UV index and Alerts25

study found more than 75% of
U.S. residents had never been
trained to perform a skin cancer
examination, and 55% had never
even observed an exam.27
In addition to physician education,
patient education and participation
also plays a key role in early
detection. A substantial portion of
melanomas are diagnosed by self
skin-examination (SSE).28-31 Many
studies have validated that when
performed correctly and routinely,
SSEs reduce the mortality and
morbidity of skin cancer in high
risk patients.32-36 However, the
majority of the population does not
perform regular SSEs, and those
performing SSEs do it incorrectly.37-39
The new mobile apps provide a
means to overcome these screening
limitations by directly facilitating
patient participation and supplying
quality education, which ensures
SSEs are performed regularly
and correctly.40-42 Using total body
photographs as objective evidence
for baseline exams, the apps permit
accurate monitoring of suspicious
lesions and make physician-patient
encounters more efficient with
physician examination paramount
for suspicious lesions.43,44 After
review of apps, the following
two were the most appropriate
for screening applications.

Cost: Free

Overview: The US National
Weather Service supplies the
current and forecast UVI and
weather for the user’s city, which
is an advantage over similar apps
that require user input of weather
conditions and UVI to determine
risk of skin damage. The “Time to
Burn” function gives an estimated
time of allowable exposure based
upon the UVI, weather conditions,
skin type, environment, and SPF. A
“UV Hazard Alert” is also featured,
which notifies the user once the
UVI exceeds a certain threshold.
Pros
•
Provides current and
forecast UVI and weather
•
Text alert when UVI is
forecast to be high
•
Provides accurate estimates
of allowable sun exposure
Cons
•
None
Conclusion: Essential prevention
tool for all patients and practitioners.

comparison. The “Lesion Tracker”
photographs and documents the
exact location of suspicious lesions.
A monthly reminder function ensures
follow up. The “Risk Calculator”
determines the absolute risk of
developing melanoma based upon
ten previously determined risk
factors.46 An introduction to the
ABCDE criteria (Asymmetry, Border
irregularity, Color variegation,
Diameter >6mm, and Evolution) is
also included for patient education.
Pros
•
Step-by-step instructions
for performing SSE
•
“Lesion tracker” facilitates
direct patient involvement
•
Allows quick identification
of high risk patients
•
Password protection for security
Cons
•
Requires a second person to
perform the full-body survey
•

No way to retrieve password
if forgotten; must uninstall
the application, resulting
in loss of all data

Conclusion: Best overall
tool for lesion tracking and
SSE for high-risk patients.
App: Doctor Mole47
Cost: $4.99

App: UMSkinCheck45
Cost: Free

Screening Applications
One problem limiting early
diagnosis of melanoma is the lack
of universal skin cancer screening
protocols. Most authorities agree
that those at high risk for melanoma
require regular screening and
monitoring (Table 2). Although a
consensus and risk factors have
been established, more than 40% of
physicians fail to routinely perform
full body skin examinations on
their high-risk patients.7,26 Absence
of formal resident education may
be a contributing factor, as one

Overview: Developed by
University of Michigan, this app
provides easy-to-follow instructions
to perform a thorough SSE. The
“Full-Body Survey” involves taking
23 photographs in 7 positions, which
serves as a baseline for future lesion
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Overview: Suspicious lesions
are photographed and computer
software analyzes lesion for
asymmetry, border, and color.
User estimates diameter and
then evolution by using the
photograph comparison function.
Pros
•
Provides objective
interpretation of ABCDE
criteria for skin lesions
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•

Reminder function
ensures follow-up

Cons
•
Computer software has
not been validated
•
Tendency of patients to
self-diagnose and delay
visit to physician
Conclusion: Potential adjunct
for lesion tracking, however,
recommendation is reserved
due to lack of validity and
potential patient misuse.

Clinical Decision Support
Applications
Dermoscopy
Lacking advanced training, the
diagnostic accuracy of skin cancer
diagnosis by PCPs is inferior to
that of dermatologists.48,49 This
discrepancy leads to a higher rate of
referral for benign lesions, increased
costs to patients, and limits access
to dermatologists. Additionally, an
increased number of malignancies
are overlooked. One solution to
this problem is dermoscopy.
Dermoscopy is a non-invasive
clinical examination that utilizes a
dermatoscope, a hand-held light
magnifier, to visualize skin lesions in
detail. This technique can distinguish
benign versus malignant lesions
based on pattern morphologies of
magnified lesions. Multiple studies
have documented the clinical
usefulness of dermoscopy in aiding
the diagnosis of melanoma. In one
study, the diagnostic sensitivity of
PCPs increased from 54% to 79%
after only one day of training.50
Another demonstrated that with
proper training and experience,
dermoscopy increased the
diagnostic accuracy by more
than 40%.51 These improvements
have been validated by multiple
meta-analyses and randomized
trials.52-55 Dermoscopy has also
proven useful for triaging skin
lesions in areas where access to
dermatologists is limited.50,56
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In the past, perceived time
commitments have been one limiting
factor to the use of dermoscopy,
as traditional contact non-polarized
dermatoscopes (NPD) required
lesion immersion with fluid before
examination. However, the advent of
polarized dermatoscopes (PD) now
allows more convenient and efficient
evaluation without immersion fluid,
and offers better visualizations of
deeper structures within the lesion.57
Several apps that are compatible
with dermatoscopes allow physicians
to capture and digitally store
high-resolution photographs.
The reviews for dermatoscopes
are limited, but several can be
purchased for less than $500.
Overall, the new DermLite DL3N58
dermatoscope is the most versatile
and has superb resolution. It
functions as both a polarized and
non-polarized dermatoscope, with
or without immersion fluid, which
allows the visualization of vessels
and red areas, as well as recognition
of regression areas by enhancing
lighter colors and blue-white areas.57
It also features new PigmentBoostTM
illumination, which allows color
temperature selection and improves
visualization of pigmented structures.
App: Dermoscopy: An Illustrated
Self-Assessment Guide59
Cost: $94.99

Overview: Based on the textbook
version from McGraw-Hill, this app
is arranged in 5 chapters of highyield dermoscopy. The first chapter
introduces the core principles of
dermoscopy, then explains “The
Two-Step Algorithm” used in
analysis of a suspicious lesion. The
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remaining chapters are organized
as a series of cases grouped by
anatomical location and major
dermoscopic features. Each case
presents a history and multiple
associated dermoscopy images,
followed by a quiz on the criteria, risk
level, diagnosis, and management
of the lesion in question.
Pros:
•
191 comprehensive cases,
including 95 melanoma cases
and most likely imitators.
•
Detailed dermoscopic
images with clear labeling
of dermoscopic features.
•
Organized layout allows easy
navigation of material.
Cons:
•
Price
Conclusion: Excellent
introductory text to dermoscopy.
App: Handyscope60
Cost: $6.99

Overview: The user’s smartphone
is connected to a compatible
dermatoscope, creating a highresolution digital dermatoscope.
Each image can be stored on
a HIPPA-compliant “FotoFinder
Hub” server or emailed to the
physician’s computer via SSLencrypted messages. This permits
instant documentation and allows
for easy consultation to online or
local dermatologists. The images
can also be stored locally to patient
profiles created within the app. For
security precautions, a password
can be enabled for the app.
Pros
•
Quality dermatoscopic images
•
Secure storage for backup
and consultation service
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•

User-friendly instant
documentation and consultation

Cons
•
Requires a dermatoscope for
premium quality images
•
Price
Conclusion: Essential pointof-care tool that will lead to
greater efficiency and efficacy
in skin cancer diagnosis.

Mobile Teledermatology
The average waiting time for
a new patient dermatologist
visit is 38 days, and the wait for
surgery may be even longer.61,62
Teledermatology (TD) may be a
viable solution to provide faster
dermatologic care, especially in
underserved areas.63 TD entails
photographing a suspicious lesion,
sending these images along with
clinically relevant information to an
online board-certified dermatologist,
or teledermatologist, who then
evaluates the lesion, gives the
diagnosis, and recommends
a treatment plan (medication,
biopsy, or referral to a local
dermatologist) within 48-72 hours.64
The clinical utility of TD depends
on the quality of the image, time
requirement for consultation,
index lesion imaged, and cost.
When image quality is poor,
the confidence and diagnostic
accuracy of teledermatologists
are low.65,66 However, when
dermoscopy is used in conjunction
with teledermatology, hence
teledermoscopy, the sensitivity
and specificity for detecting skin
cancer increase to 100% and 90%,
respectively.67-69 Studies have
shown that teledermoscopy is an
effective triage tool with comparable
diagnostic accuracy to in-person
examinations.63,69-72 Teledermoscopy
reduces costs, avoids unnecessary
biopsies, and decreases the time
to initial therapy.63,69,74 Patient
satisfaction with teledermoscopy is
nearly identical to in-person visits.75,76

Although teledermoscopy yields a
high degree of diagnostic accuracy
for index lesions, referring physicians
must not neglect the total body skin
examination, as clinically significant
lesions could go unnoticed.77
In the past, widespread
adoption of TD was limited by time
requirements for consultation,
as some web-based services
take up to nineteen minutes for
each teleconsultation.78 New
mobile apps provide a means to
compensate for these limitations
by using a HIPPA-compliant
server for both storage and
teleconsultation, allowing physicians
to simply store and forward.70,71
Mobile applications for TD exist
for both local and international
dermatologists. However, most
consultations are not covered
by insurance, so patients must
absorb the cost. Fortunately,
AccessDerm-279, an app created by
American Academy of Dermatology
(AAD), eludes this financial burden.
App: AccessDerm-279
Cost: Free

Overview: AAD-sponsored
teledermatology program
that gives PCPs who work in
participating clinics, free access
to AAD dermatologists.
Pros:
•
Free and instant access
to dermatology expertise
for underserved areas
Cons:
•
Currently limited to
only 16 states
Conclusion: Promising app
for future dermatologic care
in underserved areas.
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Patient Reference
Applications
Many mobile apps provide vast
amounts of quality information;
however, app content isn’t heavily
regulated. This creates the
potential for patient misinformation.
Directing patients toward quality
resources will not only eliminate
misinformation, but will also fill
knowledge gaps not addressed
during regular office visits.

App: Dermatology A-Z80
Cost: Free

Conclusion
Mobile application technology
offers a simple, inexpensive,
and efficient solution in the early
diagnosis and treatment of skin
cancer. From providing the ability
to quickly and efficiently screen
suspicious lesions, to obtaining
efficient referral and consultation
with a dermatologist; these apps
provide a convenient platform
to be used by both health care
professionals and the public.
Dissemination and incorporation of
these apps into everyday practice
and in public awareness campaigns
is critical to increase the early
diagnosis rate for all skin cancers.

References
1.

Overview: This app is an
excellent patient educational tool
that covers many dermatological
conditions. A description and image
for each disease is provided, as
well as the epidemiology and
etiology, signs and symptoms,
diagnostic workup, treatment, and
prognosis. Also featured is the
“Find a Dermatologist” function,
which locates dermatologists
in the surrounding area.
Pros
•
Eliminates misinformation
•
Simplicity, includes descriptions
in terms usable by a layperson
•
Quick access to local
dermatologist contact
information
Cons
•
None
Conclusion: Reliable reference
tool for all patients.

26

Rogers HW, Weinstock MA, Harris AR, et al.
Incidence estimate of nonmelanoma skin
cancer in the United States, 2006. Arch
Dermatol. 2010; 146(3):283-287.
2. American Cancer Society. Cancer Facts &
Figures 2013. Available at: http://www.cancer.
org/acs/groups/content/@
epidemiologysurveilance/documents/
document/acspc-036845.pdf. Accessibility
verified April 8, 2014.
3. Balch CM, Gershenwald JE, Soong SJ, et al.
Final version of 2009 AJCC melanoma
staging and classification. J Clin Oncol. 2009;
27:6199–6206.
4. Ahmedin J, Siegel R, Xu J, Ward E. Cancer
Statistics, 2010. CA Cancer J Clin. 2010;
60:288-296.
5. Wender, RC. Barriers to effective skin cancer
detection. Cancer. 1995; 75S(9):691-8.
6. Dolan, NC, Ng JS, Martin GJ, Robinson JK,
Rademaker AW. Effectiveness of a skin
cancer control educational intervention for
internal medicine housestaff and attending
physicians. J Gen Intern Med. 1997;
12(9):531-6.
7. Geller AC, O’Riordan, DL, Oliveria, et al.
Overcoming obstacles to skin cancer
examinations and prevention counseling for
high risk patients: results of a national survey
of primary care physicians. J Am Board Fam
Pract. 2004; 17(6):416-23.
8. Federman DG, Gravetz, JD, Kirsner, RS.
Skin cancer screening by dermatologists:
prevalence and barriers. 2002. J Am Acad
Dermatol. May;46(5):710-4.
9. Dolan NC, Martin GJ, Robinson JK,
Rademaker AW. Skin cancer control
practices among physicians in a university
general medicine practice. J Gen Intern Med.
1995;10:515–9.
10. AAMC Center for Workforce Studies, June
2010 Analysis. Available at: http://www.aamc.
org/data. Accessibility verified April 4, 2014.
11. Kiser K. 25 ways to use your smartphone.
Physicians share their favorite uses and
apps. Minn Med. 2011; 94(4):22–9.
12. Ozdalga E, Ozdalga A, Ahuja N. The
smartphone in medicine: a review of current
and potential use among physicians and
students. J Med Internet Res.
2012;14(5):e128.

West Virginia Medical Journal

13. Franko OI, Tirrell TF. Smartphone App Use
Among Medical Providers in ACGME Training
Programs. J Med Syst. 2012; 36(5):3135–9.
14. Katz-Sidlow RJ, Ludwig A, Miller S, Sidlow R.
Smarphone use during inpatient attending
rounds: prevalance, patterns and potential for
distraction. J Hosp Med. 2012; 7(8):595-9.
15. Brewer AC, Endly DC, Henley J, Amir M, et
al. Mobile applications in dermatology. JAMA
Dermatol. 2013;149(11):1300-4.
16. Elwood JM, Jopson J. Melanoma and sun
exposure: an overview of published studies.
Int J Cancer. 1997; 73:198.
17. Ting W, Schultz K, Cac NN, Peterson M,
Walling HW. Tanning bed exposure increases
the risk of malignant melanoma. Int J
Dermatol. 2007;46:1253-7.
18. Gilcrhest BA, Eller MS, Geller AC, Yaar M.
The pathogenesis of melanoma induced by
ultraviolet radiation. N Engl J Med. 1999;
340:1341
19. Hussein, MR. Ultraviolet radiation and skin
cancer: molecular mechanisms. J Cutan
Pathol. 2005; 32(3):191-205.
20. Demierre MF. Time for the national legislation
of indoor tanning to protect minors. Arch
Dermatol. 2003;139(4):520-524.
21. Stapleton J, Turrisi R, Hillhouse J,
Robinson JK, Abar B. A comparison of the
efficacy of an appearance-focused skin
cancer intervention within indoor tanner
subgroups identified by latent profile
analysis. J Behav Med. 2010; 33(3):181190.
22. Buller DB, Cokkinides V, Hall HI. Prevalence
of sunburn, sun protection, and indoor
tanning behaviors among Americans: review
from national surveys and case studies of 3
states. J Am Acad Dermatol. 2011; 65(5
Suppl 1):S114-23.
23. Zahnd WE, Goldfarb J, Scaife SL, Francis
ML. Rural-urban differences in behaviors to
prevent skin cancer: an analysis of the
Health Information National Trends Survey. J
Am Acad Dermatol. 2010; 62:950-6.
24. Virginia A. Moyer, on behalf of the U.S.
Preventive Services Task Force: Behavioral
Counseling to Prevent Skin Cancer: U.S.
Preventive Services Task Force
Recommendation Statement. Annals of
Internal Medicine. 2012; 157(1):59-65.
25. UV US – Weather Forecast, UV Index and
Alerts, by MetaOptima Technology Inc.
Itunes.apple.com, 5 April 2014 https://itunes.
apple.com/us/app/uv-us-weather-forecast-uv/
id599395265.
26. Rhodes AR, Weinstock MA, Fitzpatric TB, et
al. Risk factors for cutaneous melanoma. A
practical method of recognizing predisposed
individuals. JAMA. 1987; 258:3146
27. Wise E, Singh D, Moore M, et al. Rates of
skin cancer screening and prevention
counseling by US medical residents. Arch
Dermatol. 2009;145(10):1131-1136.
28. Brady MS, Oliveria SA, Christos PJ, et al.
Patterns of detection in patients with
cutaneous melanoma. Cancer. 2000;
89:342-347.
29. Hamidi, R, Peng, D, Cockburn, M. Efficacy of
skin self-examination for early detection of
melanoma. Int J Dermatol. 2010; 49(2):12634.
30. McPherson M, Elwood M, English DR, et al.
Presentation and detection of invasive
melanoma in a high-risk population. J Am
Acad Dermatol. 2006; 54:783-792.
31. Körner A, Coroiu A, Martins C, Wang B.
Predictors of skin self-examination before
and after a melanoma diagnosis: the role of
medical advice and patient’s level of
education. Int Arch Med. 2013; 6(1):8.

www.wvsma.org

| Original Research Article

32. Aitken JF, Elwood M, Baade PD, Youl P,
English D. Clinical whole-body skin
examination reduces the incidence of thick
melanomas. Int J Cancer. 2010; 126:450–
458.
33. Schneider JS, Moore DH 2nd, Mendelsohn
ML. Screening program reduced melanoma
mortality at the Lawrence Livermore National
Laboratory, 1984 to 1996. J Am Acad
Dermatol. 2008; 58:741–749.
34. Aitken JF, Janda M, Elwood M, et al. Clinical
outcomes from skin screening clinics within a
community-based melanoma screening
program. J Am Acad Dermatol. 2006;
54:105–114.
35. Aitken JF, Youl PH, Janda M, et al. Increase
in skin cancer screening during a communitybased randomized intervention trial. Int J
Cancer. 2006; 118:1010–1016.
36. Berwick M, Begg CB, Fine JA, Roush GC,
Barnhill RL. Screening for cutaneous
melanoma by skin self-examination. J Natl
Cancer Inst. 1996; 88:17–23.
37. Carli P, De Giorgi V, Palli D, et al. Selfdetected cutaneous melanomas in Italian
patients. Clin Exp Dermatol. 2004;
29:593-596.
38. Arnold MR, DeJong W. Skin self-examination
practices in a convenience sample of US
university students. Prev Med. 2005;
40:268-273.
39. Weinstock MA, Risica PM, Martin RA, et al.
Melanoma early detection with thorough skin
self-examination: the “Check It Out”
randomized trial. Am J Prev Med.
2007;32:517–24.
40. Oliveria SA, Dusza SW, Phelan DL, et al.
Patient adherence to skin self-examination:
effect of nurse intervention with photographs.
Am J Prev Med. 2004; 26:152–155.
41. Robinson JK, Turrisi R, Stapleton J. Efficacy
of a partner assistance intervention designed
to increase skin self-examination
performance. Arch Dermatol. 2007;
143:37–41.
42. McWhirter JE, Hoffman-Goetz L. Visual
images for patient skin self-examination and
melanoma detection: a systematic review of
published studies. J Am Acad Dermatol.
2013, 69:47-55.
43. Feit NE, Dusza SW, Marghoob AA.
Melanomas detected with the aid of total
cutaneous photography. Br J Dermatol.
2004;150:706-714.
44. Rademaker, M, Oakley, A. Digital monitoring
by whole body photography and sequential
digital dermoscopy detects thinner
melanomas. J Prim Health Care. 2010;
2(4):268-72.
45. UMSkinCheck, by The University of Michigan
Technology Inc. Itunes.apple.com, 6 April
2014 https://itunes.apple.com/us/app/
umskincheck/id522498604.
46. Fears TR, Guerry D 4th, Pfeiffer RM, et al.
Identifying individuals at high risk of
melanoma: a practical predictor of absolute
risk. J Clin Oncol. 2006; 24(22):3590-6.
47. Doctor Mole – Skin Cancer App, by
RevoSoft. Itunes.apple.com, 9 April 2014
https://itunes.apple.com/us/app/doctor-moleskin-cancer-app/id562711395.
48. Chen SC, Pennie ML, Kolm P, et al.
Diagnosing and managing cutaneous
pigmented lesions: primary care physicians
versus dermatologists. J Gen Intern Med.
2006;21(7):678–682.
49. Corbo MD, Wismer J. Agreement between
dermatologists and primary care practitioners
in the diagnosis of malignant melanoma:
review of the literature. J Cutan Med Surg.
2012; 16(5):306-10.

50. Argenziano G, Puig S, Zalaudek I, et al.
Dermoscopy improves accuracy of primary
care physicians to triage lesions suggestive
of skin cancer. J Clin Oncol. 2006;
24(12):1877–1882.
51. Kittler H, Pehamberger H, Wolff K, et al.
Diagnostic accuracy of dermoscopy. Lancet
Oncol. 2002; 3:159-165.
52. Vestergaard ME, Macaskill P, Holt PE, et al.
Dermoscopy compared with naked eye
examination for the diagnosis of primary
melanoma: a meta-analysis of studies
performed in a clinical setting. Br J Dermatol.
2008; 159:669-676.
53. Nachbar F, Stolz W, Merkle T, et al. The
ABCD rule of dermatoscopy. High
prospective value in the diagnosis of doubtful
melanocytic skin lesions. J Am Acad
Dermatol. 1994; 30:551-559.
54. Bafounta ML, Beauchet A, Aegerter P, et al:
Is dermoscopy (epiluminescence
microscopy) useful for the diagnosis of
melanoma? Results of a meta-analysis using
techniques adapted to the evaluation of
diagnostic tests. Arch Dermatol. 2001;
137:1343-1350.
55. Carli P, de Giorgi V, Chiarugi A, et al. Addition
of dermoscopy to conventional naked-eye
examination in melanoma screening: a
randomized study. J. Am. Acad. Dermatol.
2004; 50:683–689.
56. Menzies, SW, Emergy, J, Staples, M, et al.
Impact of dermoscopy and short-term
sequential digital dermoscopy imaging for the
management of pigmented lesions in primary
care: a sequential intervention trial. Br J
Dermatol. 2009; 161(6):1270-7.
57. Benvenuto-Andrade C, Dusza SW, Agero AL,
et al. Differences between polarized light
dermoscopy and immersion contact
dermoscopy for the evaluation of skin
lesions. Arch Dermatol. 2007; 143:329-338.
58. DermLite DL3N Dermatoscope, by 3Gen.
Dermlite.com, 8 April 2014 http://dermlite.
com/products/dermlite-dl3n.
59. Dermoscopy: An Illustrated Self-Assessment
Guide, by Usatine Media LLC. Itunes.apple.
com, 4 April 2014 https://itunes.apple.com/
us/app/dermoscopy-illustrated-self/
id453996300.
60. Handyscope by FotoFinder Systems GmbH.
Itunes.apple.com, 8 April 2014 https://itunes.
apple.com/us/app/handyscope/id387895114.
61. Tsang MW, Resneck Jr JS. Even patients
with changing moles face long dermatology
appointment wait-times: a study of simulated
patient calls to dermatologist. J Am Acad
Dermatol. 2006; 55:54-8.
62. Suneja T, Smith ED, Chen GJ, et al. Waiting
times to see a dermatologist are perceived
as too long by dermatologists: implications
for the dermatology workforce. Arch
Dermatol. 2001;137:1303-7.
63. van der Heijden JP, de Keizer NF, Bos JD,
Spuls PI, Witkamp L. Teledermatology
applied following patient selection by general
practitioners in daily practice improves
efficiency and quality of care at lower cost. Br
J Dermatol. 2011; 165:1058–106.
64. Whited JD. Teledermatology research review.
Int J Dermatol. 2006; 45:220-9.
65. Oakley AM, Reeves F, Bennett J., Holmes
SH, Wickham H. Diagnostic value of written
referral and/or images for skin lesions. J
Telemed Telecare. 2006;12(3):151-8.
66. Mallett RB. Teledermatology in practice. Clin
Exp Dermatol. 2003; 28:356-359.
67. Griffiths AD. Improving melanoma diagnosis
in primary care – a tele-dermatoscopy
project. J Telemed Telecare. 2010;
16:185-186.

www.wvsma.org

68. Morton CA, Downie F, Auld S. et al.
Community photo-triage for skin cancer
referrals: an aid to service delivery. Clin Exp
Dermatol. 2011; 36:248–254.
69. Tan E, Yung A, Jameson M, Oakley A,
Rademaker M. Successful triage of patients
referred to a skin lesion clinic using
teledermoscopy (IMAGE IT trial). Br J
Dermatol. 2010; 162:803–811.
70. Kromer S, Fruhauf J, Campbell TM, et al.
Mobile teledermatology for skin tumour
screening: diagnostic accuracy of clinical and
dermoscopic image tele-evaluation using
cellular phones. Br J Dermatol.
2011;164:973-9.
71. Massone, C, Hofmann-Wellenhof, R,
Ahlgrimm-Siess, V, Gabler, G, Ebner, C,
Soyer, HP. Melanoma screening with cellular
phones. PLoS One. 2007; 2(5):e483
72. Barbieri, JS, Nelson, CA James, WD. The
reliability of teledermatology to triage
inpatient dermatology consultations. JAMA
Dermatol. 2014; 150(4):419-24.
73. Shapiro, M, James, WD, Kessler, R, et al.
Comparison of skin biopsy triage decisions in
49 patients with pigmented lesions and skin
neoplasms: store-and-forward
teledermatology vs face-to-face dermatology.
Arch Dermatol. 2004; 140(5):525-8.
74. Hsiao, JL, Oh, DH. The impact of store-andforward teledermatology on skin cancer
diagnosis and treatment. J Am Acad
Dermatol. 2008; 59(2):260-7.
75. Hsueh, MT, Eastman, K, McFarland, LV,
Raugi, GJ, Reiber, GE. Teledermatology
patient satisfaction in the pacific northwest.
Tele. J E Health. 2012; 18(5):377-381.
76. Whited, JD, Hall, RP, Foy, ME, et al. Patient
and clinician satisfaction with a store-andforward teledermatology consult system.
Telemed. J E-Health. 2004; 10(4):422-31.
77. Viola KV, Tolpinrud WL, Gross CP, et al.
Outcomes of referral to dermatology for
suspicious lesions: implications for
teledermatology. Arch Dermatol. 2011;
147(5):556-560.
78. Lasierra N, Alesanco A, Gilaberte Y, Magallón
R, García J. Lessons learned after a
three-year store and forward teledermatology
experience using internet: Strengths and
limitations. Int J Med Inform. 2012; 81(5):33243.
79. AccessDerm 2, by American Academy of
Dermatology. Itunes.apple.com, 6 April 2014,
https://itunes.apple.com/us/app/
accessderm-2/id574802400.
80. Dermatology A-Z, by American Academy of
Dermatology. Itunes.apple.com, 5 April 2014
https://itunes.apple.com/us/app/dermatologya-z/id661334295.
81. Wolff T, Tai E, Miller T. Screening for skin
cancer: an update of the evidence for the
U.S. Preventive Services Task Force. Ann
Intern Med. 2009;150(3):194–198.
82. Rigel DS, Friedman RJ, Kopf AW, et al.
Importance of complete cutaneous
examination for the detection of malignant
melanoma. J Am Acad Dermatol.
1986;14(5):857–60.
83. American Cancer Society. Prevention and
early detection. Available at: http://www.
cancer.org/acs/groups/cid/documents/
webcontent/003184-pdf. Accessibility verified
April 10, 2014.
84. American Medical Association. Cancer
screening guidelines. Available at: http://
www.ama-assn.org. Accessibility verified
April 10, 2014.

September/October 2015 | Vol. 111

27

Original Research Article |

Appendix
Table 1. Smartphone mobile applications for skin cancer prevention, screening, and management.
Application

Function

Suggested user

Platform

Cost

UV US – Weather
Forecast, UV index and
Alerts25

Prevention

All patients

iPhone

Free

UMSkinCheck45

Risk assessment
Screening

High risk patients
Health care providers
Students

iPhone

Free

Doctor Mole47

Screening

High-risk patients

iPhone
Android

$4.99

Dermoscopy: An
Illustrated SelfAssessment Guide59

Medical education

Health care providers
Students

iPhone

$94.99

Clinical decision
support tool
Online Consultation

Health care providers
Students

iPhone

$6.99

Online Consultation

Health care providers
Students

iPhone
Android

Free

Patient Reference

All patients

iPhone
Android

Free

Handyscope60
AccessDerm79
Dermatology A-Z80

Table 2. Guidelines for skin cancer screening.
Authority

Recommendations

United States
Preventive
Service Task
Force81

• Insufficient evidence to determine whether a decrease in mortality occurs with routine whole body
skin examination in low risk patients by PCPs or self-examination. However, physicians should
remain alert for skin lesions with malignant features while performing physical examinations.
• Recommends that patients at high risk of melanoma, such as those with first-degree family history,
be referred to dermatologist for screening examinations and monitoring.

American
Academy of
Dermatology82

• Recommends all individuals adopt a comprehensive sun protection program and perform regular
skin self-examinations; advocates follow up evaluation on any unusual skin changes.

American Cancer
Society83

• Recommends skin examination and cancer-related checkup every three years in patients 20-40
years old and annually for those > 40 years of age.

American
Medical
Association84

• Advises skin self-examination monthly and yearly physician skin-examinations in patients at
moderately increased risk.
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